Big biotech companies have flushed $100 billion in stock buybacks down the toilet
October 30, 2018 at 11:52 AM EDT
Six companies spent billions just to end up with a negative rate of return, according to a new analysis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.